# Pamela Shaddock

Pamela Shaddock is a co-founder of Coils to Locs, a textured-wig company created to help women with coily and curly hair access wigs during medical hair loss. The company sells directly and partners with hospitals and cancer centers.

- Profile: https://b2binfluencer.marketing/creators/pamela-shaddock/
- LinkedIn: https://www.linkedin.com/in/pamelashaddock
- LinkedIn followers: 1,776
- YouTube: https://www.youtube.com/channel/UCx57LCf_qeNghYsExm36Baw
- Topics: healthcare
- Based on 13 dated posts, latest 2026-09-29

## Summary

Pamela Shaddock is most useful for textured-wig access, patient education, and hospital partnership credibility.

- Best for: Hospital oncology patient-services or cancer-center campaigns expanding textured wig access and education.
- Not for: Mass consumer beauty campaigns needing large cross-platform reach or paid short-form video.
- Check first: Confirm pricing, terms, audience data, and independently verified hospital partner figures.

### Takeaways

- Patients could not find a wig reflecting natural hair in hospital boutiques.
- Shaddock reports 29 hospital partners and a goal of 40 by end of 2026.
- They presented Wigs 101 for Alopecia Areata and spoke at National Alopecia Areata Foundation annual conference.

## Main ideas

- **Textured-hair options in medical settings are a standard of care, not a nice-to-have**: Across the posts, the argument is that a patient with medical hair loss should not leave a hospital boutique empty-handed because no wig matches their hair. Pamela Shaddock frames that absence as a care-quality failure, not a personal inconvenience, and links it to the loss of an insurance benefit: the product gap and access gap are one problem. The founding story repeats the same concrete details — the year, the city, the number of boutiques — to make the case.
- **A benefit a patient can see themselves in is a benefit a patient will actually use**: The access argument is specific: when the only available product does not match a patient’s hair, the insurance or FSA benefit they already hold goes unused. Closing the product gap makes that benefit work. Naming hair types 3C–4C ties the claim to a defined group, while the posts describe the alternative as a loss: being asked to compromise identity to use a benefit.
- **A stocked wig program is a hospital business case, not a compliance checkbox**: For hospital staff, the argument shifts from patient dignity to the hospital’s own interests, pairing equity with operational concerns. The posts tell hospitals what an existing partner supposedly already knows: stocking a textured option supports demand, reputation, and retention. That’s a different pitch from simply asking a health system to do the right thing.
- **A patient asking for the brand by name is itself an act of advocacy**: The “Ask For Coils to Locs By Name” campaign builds demand from the patient side rather than asking only hospitals to change their shelves. Pamela Shaddock frames the request as more than a purchase: it is a concrete step a patient or family member can take after scanning a wig wall and not seeing themselves represented.
- **Education through patient-advocacy organizations is the main public outreach format**: The posts show the company teaching through named patient organizations and their stages, rather than relying on advertising. Education takes a repeatable format: a webinar, then a conference presentation and audience Q&A, reaching patients and professionals where the topic is already being discussed.
- **Growth is reported as a countable hospital network with a named target**: The posts report the company’s current count and target in plain numbers, turning expansion into a public progress report rather than a vague claim of traction. They also log funding, awards, and event participation, describing the company’s growth as steady and intentional.
- **The company is placed inside a longer arc of Black business and health access**: Cultural moments give the founding problem a historical frame rather than serving as product promotion. The argument casts access as ongoing work built through individual businesses and partnerships, and backs it with a cited figure.

## Work to read

- [Ask for Coils to Locs by name: the gap in hospital wig supply](https://www.linkedin.com/posts/pamelashaddock_coilstolocs-texturedhair-askbyname-activity-7464654018452180992-qnUn)
- [Dana-Farber feature and the founding timeline](https://www.linkedin.com/posts/pamelashaddock_coilstolocs-medicalhairloss-texturedwigs-activity-7467196703796887552-M0Vj)
- [The partner pitch: 29 hospital partners, dignity, and what a wig program does for a hospital](https://www.linkedin.com/posts/pamelashaddock_hospitalpartnership-healthequity-cancercare-activity-7486435077325832192-L8I5)
- [Six months of 2026: education, conferences, partners, and funding](https://www.linkedin.com/posts/pamelashaddock_healthcare-womenownedbusiness-cancersupport-activity-7480591596745531392-JkPF)
- [Juneteenth post: where the company places itself in Black business and access](https://www.linkedin.com/posts/pamelashaddock_juneteenth-blackentrepreneurship-blackwomeninbusiness-activity-7473746279307632640-t_wc)

## Brand relationships

- **Coils to Locs** (owned_business)
- **Dana-Farber Cancer Institute** (disclosed_partnership)
- **National Alopecia Areata Foundation** (disclosed_partnership)
- **Chasm** (sponsor)
- **Rockland Trust** (mention)
- **Boston Rhythm Riders** (mention)

## Partnerships

Coils to Locs, the textured-wig company Pamela Shaddock co-founded, partners with hospitals, cancer centers, and nonprofits rather than running advertising-style sponsorships. The posts describe two main partnership routes: stocking 3C–4C textured wigs in hospital boutiques and cancer-center wig programs, and providing patient and clinician education. Shaddock reports 27+ hospital and cancer-center partners, then 29, with a goal of 40 by the end of 2026. The patient-facing “Ask For Coils to Locs By Name” campaign encourages people to request the brand at their hospital boutique. The posts make a practical case for buyers: a stocked 3C–4C option lets patients use a cranial prosthesis insurance benefit for a wig they can see themselves in, while visible textured-hair representation signals patient-centered care. Nonprofit and community activity includes product donations, conference presentations, and local fundraisers. Ask for pricing, contract terms, and lead times; the posts provide no rate card, sponsorship policy, or partnership inquiry page.

## Alternatives

- Bami Adenipekun: Choose Bami over Pamela Shaddock when the partnership is primarily about patient voice, trauma-informed engagement, or health-equity listening in ethnic-minority communities—not stocking textured wigs in a hospital boutique. Bami's posts show them turning a family cancer death and personal cancer experience into patient-advocacy work, writing a book on life after trauma, and building an engagement event around what happens after a survey or focus group ends. For an oncology patient-services company seeking community consultation, cultural-safety input, or patient-advisory design, Bami's firsthand patient narrative and engagement framing may be more directly useful than a product-access partner.
- Geoff Vercauteren: Choose Geoff over Pamela Shaddock when the hospital partnership is mainly about workforce or training within a health system, not patient-facing wig access. Geoff's posts show them representing Tufts Medicine and Lowell General Hospital at a life-sciences workforce roundtable, discussing youth career exploration, high-school-to-healthcare pathways, apprenticeships, and partnerships with colleges, workforce boards, and community organizations. They also cover a UW Health conference on healthcare workforce development and apprenticeship programs. If the buyer needs to co-design a patient-navigator, oncology-nurse, or boutique-staff training pipeline, Geoff's workforce-development focus is a closer fit than a product-access brand.
- Jean Stimola-Sposaro: Choose Jean over Pamela Shaddock when the partnership is about patient-data governance, decentralized clinical-trial design, or the return of individual health data in oncology research—not boutique stocking. Jean's posts analyze ownership of clinical-trial data between investigators and sponsors, argue that participants are largely absent from the ownership conversation, and discuss a European Delphi study on decentralized-trial barriers, including a 69% dropout at the digital consent screen. For a patient-services company supporting trials, consent design, or patient-data policy, Jean's evidence and framing are more directly relevant than a wig-access partnership.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/